Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin in Type 2 Diabetic Patients With Microalbuminuria
NCT00471549Phase 4Completed
- Sponsor
- Aarhus University
- Start
- Jun 1991
- Modality
- Small Molecules
01
Overview
Phase 4 trial of simvastatin in type 2 diabetes mellitus (T2DM), sponsored by Aarhus University. Primary endpoint: Relative reduction in circulating osteoprotegerin levels at 18 weeks. Started Jun 1991; status: completed.
02
Drugs
simvastatin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00471549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00471549.